PAPA (Papa Medical) Other Current Receivables: $0.00 Mil (As of Mar. 2025)


What is Papa Medical Other Current Receivables?

Papa Medical PAPA Other Current Receivables is $0.00 Mil as of Mar. 2025.

Papa Medical's Other Current Receivables for the quarter that ended in Mar. 2025 was $0.00 Mil.

Papa Medical's quarterly Other Current Receivables declined from Sep. 2024 ($0.00 Mil) to Dec. 2024 ($0.00 Mil) but then stayed the same from Dec. 2024 ($0.00 Mil) to Mar. 2025 ($0.00 Mil).

Papa Medical Other Current Receivables Related Terms

Papa Medical Other Current Receivables Historical Data

* Premium members only.

The historical data trend for Papa Medical's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Papa Medical Other Current Receivables Chart

Papa Medical Annual Data
Trend Dec22 Dec23 Dec24
Other Current Receivables
0.00 0.00 0.00

Papa Medical Quarterly Data
Dec22 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Other Current Receivables Get a 7-Day Free Trial Premium Member Only 0.00 0.00 0.00 0.00 0.00

Papa Medical Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

What does a Other Current Receivables of $0.00 Mil mean?
Papa Medical (PAPA) has a Other Current Receivables of $0.00 Mil as of Mar. 2025. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Papa Medical and its competitors.
Is Papa Medical's Other Current Receivables too high?
Papa Medical's current Other Current Receivables is $0.00 Mil.
How does Papa Medical's Other Current Receivables compare to ?
Papa Medical's Other Current Receivables of $0.00 Mil can be compared against companies in the Tobacco Products industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Receivables for a Tobacco Products company?
A good Other Current Receivables depends on the Tobacco Products industry context. However, Other Current Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Receivables mean?
A high Other Current Receivables can signal that a stock is expensive relative to its fundamentals. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Papa Medical and its competitors. Papa Medical's current Other Current Receivables is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Papa Medical stock overvalued right now?
Papa Medical (PAPA) has a current Other Current Receivables of $0.00 Mil. The current Other Current Receivables is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Receivables calculated?
Other Current Receivables is calculated from a company's financial statements. For Papa Medical (PAPA), the current Other Current Receivables is $0.00 Mil as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Papa Medical Business Description

Comparable Companies
Address 202 North California Ave, City of Industry, CA, USA, 91744
Papa Medical Inc is the first end-to-end cannabis dosing solution provider in the U.S. that possesses the medical atomization or nebulizing background and sells nebulizers. The company deeply engages in key activities in the cannabis and consuming E-vapors industry, from research and development, formulation design, e-liquid production, and e-liquid filling to e-liquid co-packing services. It is engaged in the research and development, design, commercialization, sales, marketing and distribution of branded e-cigarettes and cannabis E-vapors.